Table 3.
Pre-NIPPV monitoring and NIPPV success.
|
| |
|---|---|
| CHARACTERISTICa | NIPPV |
|
| |
| N = 23 | |
|
| |
| Last vitals prior to NIPPV | |
|
| |
| Systolic blood pressure, mean ± SD (n = 17) | 123.24 ± 61.82 |
|
| |
| Patient hypotensiveb, n (%) | 4 (23.5%) |
|
| |
| SpO2 (%), mean ± SD | 88.96 ± 8.90 |
|
| |
| SpO2 <90%, n (%) | 13 (56.5%) |
|
| |
| On monitoring prior to NIPPV, n (%) | 23 (100.0%) |
|
| |
| SpO2 monitoring, n (%) | 22 (95.7%) |
|
| |
| Blood pressure monitoring, n (%) | 15 (65.2%) |
|
| |
| Cardiac monitoring, n (%) | 4 (17.4%) |
|
| |
| Diagnostics and findings prior to NIPPV | |
|
| |
| Chest X-ray, n (%) | 5 (21.7%) |
|
| |
| Bilateral infiltrates (n = 3) | 2 (66.7%) |
|
| |
| Pulmonary edema (n = 3) | 1 (33.3%) |
|
| |
| Ultrasound, n (%) | 15 (65.2%) |
|
| |
| B lines (n = 11) | 7 (63.6%) |
|
| |
| Pleural effusion (n = 11) | 2 (18.2%) |
|
| |
| Cardiac finding (n = 11) | 2 (18.2%) |
|
| |
| Blood gas obtained, n (%) | 7 (30.4%) |
|
| |
| NIPPV type, n (%) | |
|
| |
| CPAP | 1 (4.3%) |
|
| |
| BiPAP | 22 (95.7%) |
|
| |
| Patient respiratory status 30 minutes following NIPPV, n (%) | |
|
| |
| Improved | 16 (69.6%) |
|
| |
| Unchanged or worsened | 7 (30.4%) |
|
| |
| SpO2 <90% prior to NIPPV, n (%) | 13 (56.5%) |
|
| |
| Achieved SpO2 >90% after NIPPV, n (%) | 11 (84.6%) |
|
| |
| Patient required intubation, n (%) (n = 20) | 4 (20.0%) |
|
| |
| NIPPV discontinued during time in ED, n (%) (n = 19) | 2 (10.5%) |
|
| |
SpO2, oxygen saturation; CPAP, continuous positive airway pressure; BiPAP, bi-level positive airway pressure.
a For characteristics with missing information, the number of patients with available information is noted in parentheses.
b Hypotension was defined as SBP <100 for age >12 years, <80 for ages 1–12, and <70 for <1 year old.